Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-01-04 @ 1:50 AM
Study NCT ID:
NCT05011669
Status:
COMPLETED
Last Update Posted:
2024-04-18
First Post:
2021-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia
Sponsor:
Sumitomo Pharma (Suzhou) Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DSPCLAT-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None